ENSC
Ensysce Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.46
+1.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -11.40x
- Price / sales
- 7.66x
- Price / cash flow
- -1.01x
Enterprise value
- Enterprise value
- $8.1M
- EV / sales
- 6.96x
- EV / EBITDA
- -0.64x
- EV / EBIT
- -0.64x
- Market cap
- $8.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026